Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
49 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

VRAX — Virax Biolabs Group Limited Dilution Risk Tracker

Track VRAX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRAX — Get alerts when the score changes →

As of October 13, 2026, Virax Biolabs Group Limited (VRAX) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Virax Biolabs Group Limited has a market capitalization of $1.07M, 579.2K shares outstanding, 6 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.17 below $1 exchange minimum
🔔 Track VRAX — Get forecast alerts →

Market Data

Market Cap$1.07M
Shares Outstanding579.2K
FloatN/A
Cash$3.44M
Debt$538.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore49/100DilutionWatch score record
Shares Outstanding579.2KVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$1.07MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: 6-K 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

6 institutional holders · 35.0K shares
#1 Xtx Topco Ltd 21.4K shares
#2 UBS Group AG 7.5K shares
#3 National Bank of Canada/FI/ 6.0K shares
+ 3 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.6K
Days to Cover1.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

6-K 8K EVENT 2026-07-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VRAX Dilution Snapshot

Virax Biolabs Group Limited (VRAX) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VRAX's DilutionScore is currently 49/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 45/100 (Medium risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202649/100MEDIUM6 days
Sep 07 – Oct 07, 202645/100MEDIUM31 days
Jul 16 – Sep 06, 202640/100MEDIUM52 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VRAX shares outstanding have decreased 0.0% from 7.42M (Mar 2026) to 7.42M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 29, 20267.42M5.98M▼ 1.99%
May 23, 20267.42M6.10M▼ 5.11%
Apr 20, 20267.42M6.43M▲ 16.79%
Mar 26, 20267.42M5.50M▲ 1.31%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VRAX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VRAX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VRAX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for VRAX
VRAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.